Literature DB >> 23203181

Adverse reaction; patent blue turning patient blue.

Meera Joshi1, Matthew Hart, Farid Ahmed, Sandy McPherson.   

Abstract

The authors report a severe anaphylactic reaction to Patent Blue V dye used in sentinel node biopsy for lymphatic mapping during breast cancer surgery to stage the axilla. Patent Blue dye is the most widely used in the UK; however, adverse reactions have been reported with the blue dye previously. This case highlights that reactions may not always be immediately evident and to be vigilant in all patients that have undergone procedures using blue dye. If the patients are not responding appropriately particularly during an anaesthetic, one must always think of a possible adverse reaction to the dye. All surgical patients should give consent for adverse reactions to patent blue dye preoperatively. Alternative agents such as methylene blue are considered.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23203181      PMCID: PMC4544342          DOI: 10.1136/bcr-2012-007339

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  12 in total

Review 1.  Anaphylactic response to blue dye during sentinel lymph node biopsy.

Authors:  Corinne Bézu; Charles Coutant; Anne Salengro; Emile Daraï; Roman Rouzier; Serge Uzan
Journal:  Surg Oncol       Date:  2010-11-11       Impact factor: 3.279

2.  American Society of Clinical Oncology guideline recommendations for sentinel lymph node biopsy in early-stage breast cancer.

Authors:  Gary H Lyman; Armando E Giuliano; Mark R Somerfield; Al B Benson; Diane C Bodurka; Harold J Burstein; Alistair J Cochran; Hiram S Cody; Stephen B Edge; Sharon Galper; James A Hayman; Theodore Y Kim; Cheryl L Perkins; Donald A Podoloff; Visa Haran Sivasubramaniam; Roderick R Turner; Richard Wahl; Donald L Weaver; Antonio C Wolff; Eric P Winer
Journal:  J Clin Oncol       Date:  2005-09-12       Impact factor: 44.544

3.  Sentinel lymph nodes containing very small (<0.1 mm) deposits of metastatic melanoma cannot be safely regarded as tumor-negative.

Authors:  Rajmohan Murali; Chitra DeSilva; Stanley W McCarthy; John F Thompson; Richard A Scolyer
Journal:  Ann Surg Oncol       Date:  2012-01-21       Impact factor: 5.344

Review 4.  A comparison of the adverse reactions associated with isosulfan blue versus methylene blue dye in sentinel lymph node biopsy for breast cancer.

Authors:  Sarmela Thevarajah; Tara L Huston; Rache M Simmons
Journal:  Am J Surg       Date:  2005-02       Impact factor: 2.565

5.  Adverse reactions to patent blue V dye - The NEW START and ALMANAC experience.

Authors:  L Barthelmes; A Goyal; R G Newcombe; F McNeill; R E Mansel
Journal:  Eur J Surg Oncol       Date:  2009-11-24       Impact factor: 4.424

6.  Early recurrence in sentinel lymph node positive stage III melanoma patients.

Authors:  Justin J Baker; David W Ollila; Allison M Deal; Jill Frank; Keith D Amos; Michael O Meyers
Journal:  Am Surg       Date:  2012-07       Impact factor: 0.688

7.  A prospective trial comparing 1% lymphazurin vs 1% methylene blue in sentinel lymph node mapping of gastrointestinal tumors.

Authors:  Mehul Soni; Sukamal Saha; Alpesh Korant; Patti Fritz; Bishan Chakravarty; Saad Sirop; Adam Gayar; Douglas Iddings; David Wiese
Journal:  Ann Surg Oncol       Date:  2009-05-30       Impact factor: 5.344

Review 8.  [Anaphylactic shock due to patent blue: four case report and review of literature].

Authors:  N Lucas; S Benay Interne; P Laine; B Nicolie; E Fondrinier
Journal:  J Gynecol Obstet Biol Reprod (Paris)       Date:  2010-01-15

9.  Methylene blue dye--a safe and effective alternative for sentinel lymph node localization.

Authors:  Philip Varghese; Alaa Talaat Abdel-Rahman; Samira Akberali; Azad Mostafa; Jennifer May Gattuso; Robert Carpenter
Journal:  Breast J       Date:  2008 Jan-Feb       Impact factor: 2.431

10.  Complications of methylene blue dye in breast surgery: case reports and review of the literature.

Authors:  Fj Reyes; Mb Noelck; C Valentino; L Grasso-Lebeau; Je Lang
Journal:  J Cancer       Date:  2010-12-08       Impact factor: 4.207

View more
  3 in total

1.  Can methylene blue dye be used as an alternative to patent blue dye to find the sentinel lymph node in breast cancer surgery?

Authors:  Asieh Sadat Fattahi; Alireza Tavassoli; Omid Rohbakhshfar; Ramin Sadeghi; Abbas Abdollahi; Mohammad Naser Forghani
Journal:  J Res Med Sci       Date:  2014-10       Impact factor: 1.852

2.  Patent Blue dye allergy and the deep inferior epigastric perforator free flap: a unique interaction.

Authors:  Shanesh Kumar; Raminder Dhillon; Snehal Shah; Dean C White; Warren Matthew Rozen
Journal:  Clin Case Rep       Date:  2018-02-08

3.  Case report: Atypical anaphylactic reaction to Patent Blue V dye during breast cancer surgery.

Authors:  Stanka Misir Šitum; Iva Korečić Zrinjščak; Maja Pečvarac; Andrea Šoštar; Ana Žaja; Tea Tot
Journal:  Front Oncol       Date:  2022-09-16       Impact factor: 5.738

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.